Dupont Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2,012
| Closed | -$290K | – | 1439 |
|
|
2020
Q1 | $290K | Buy |
2,012
+276
| +16% | +$39.8K | 0.01% | 875 |
|
|
2019
Q4 | $355K | Sell |
1,736
-1,786
| -51% | -$365K | 0.01% | 1008 |
|
|
2019
Q3 | $283K | Buy |
+3,522
| New | +$283K | 0.01% | 1021 |
|
|
2019
Q2 | – | Sell |
-4,350
| Closed | -$372K | – | 1286 |
|
|
2019
Q1 | $372K | Buy |
+4,350
| New | +$372K | 0.01% | 869 |
|